# US 2017/0281640 A1 · Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281640 A1
- Document ID: US20170281640A1
- Status: Published application
- Kind: A1
- Application number: 15/089,980
- Filed: 2016-04-04
- Published: 2017-10-05
- Earliest claimed: 2016-04-04
- Assignees: Productos Maver, S.A. de C.V.
- Applicants: Productos Maver, S.A. de C.V.
- Inventors: Silvia Romero Medina; Jorge Castro Luna; Karim Saul Solorza Camacho; Alejandro Maldonado Pérez
- Web page: https://patentgrep.com/patent/US20170281640A1

## CPC

- A61K 31/5415: ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/1623: {Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules}
- A61K 9/4858: {Organic compounds}
- A61K 31/133: having hydroxy groups, e.g. sphingosine
- A61K 31/27: of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A61K 9/1635: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/1652: {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623)}
- A61K 9/4866: {Organic macromolecular compounds}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Provided herein is a stable pharmaceutical composition including meloxicam and methocarbamol in the form of granules, including a meglumine and sodium citrate complex to improve solubility. The pharmaceutical compositions are administered simultaneously and are kept separated in the pharmaceutical form that is administered. Also provided herein are methods for the treatment of disorders associated with muscle, skeletal muscle, and pain.

## Claims

### Claim 1

An oral pharmaceutical composition comprising:
i. a first granulated material containing meloxicam, meglumine, sodium citrate, a surfactant agent, a diluent agent, a disintegrant agent, an agglutinant agent, and a moisturizing solution with a mixture of a pharmaceutically acceptable alcohol and water;
ii. a second granulated material containing methocarbamol or its pharmaceutically acceptable salts, an agglutinant agent, and a moisturizing solution with a mixture of ethanol and water; and
iii. optionally, a lubricant agent,
wherein the proportion of sodium citrate to meglumine is in the range of 8:1 to 4:1.

### Claim 2 (depends on 1)

The pharmaceutical composition of claim 1, wherein the methocarbamol and meloxicam drugs are not in the same granule.

### Claim 3 (depends on 1)

The pharmaceutical composition of claim 1, wherein the first and second granulated materials are contained in a capsule.

### Claim 4 (depends on 1)

The pharmaceutical composition of claim 1, wherein the first granulated material is obtained by
preparing a first granulation solution comprising meglumine and a mixture of ethanol and water;
adding meloxicam to the first granulation solution;
manufacturing a first granulation support comprising a mixture of sodium citrate with a tensioactive agent, a diluent agent, a disintegrant agent, and an agglutinant agent;
moisturizing the first granulation support with the first granulation solution until the granulation point to form a meloxicam granule;
and the second granulated material is obtained by
preparing a second granulation solution comprising a mixture of a pharmaceutically acceptable alcohol and water;
manufacturing a second granulation support comprising an agglutinant agent and methocarbamol; and
moisturizing the second granulation support with the second granulation solution until the granulation point to form a methocarbamol granule; wherein
the meloxicam granule and the methocarbamol granule are optionally mixed with a lubricant.

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is useful for the treatment of disorders associated with muscle and problems associated with moderate to severe pain.

### Claim 7

(canceled)
